Insights On Trial Design

  1. Health Literacy Is The Hidden Enrollment Barrier: Close The Comprehension Gap 8/5/2025

    In a landscape where health equity and patient-centered research are imperatives, a Patient Experience Organization (PXO) offers a scalable system to ensure every patient understands, engages, and stays.

  2. Why Engagement Matters In Clinical Trial 5/21/2025

    Here we explore the concept of "patient activation," which empowers individuals to take an active role in their healthcare decisions.

  3. FDA Draft Guidance On Diversity Action Plan Requirements 10/24/2024

    Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.

  4. Strengthening Psychiatric Eligibility In CNS Trials 2/21/2025

    Learn how Independent Psychiatric Eligibility Reviews provide a standardized, objective approach to screening, improving diagnostic accuracy, reducing bias, and enhancing trial integrity.

  5. 5 Essential Steps To Implementing Decentralized Clinical Trials Globally 9/15/2025

    Running a global decentralized clinical trial requires a strategy that balances the FDA's focus on technology accessibility with the EMA's emphasis on validation and comprehensive documentation.

  6. How RWD Reshapes Patient Recruitment Strategies 8/13/2025

    Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.

  7. Overview Of Endometrial Cancer: Global Clinical Trials Landscape 5/17/2024

    This FAQ delves into the latest developments in endometrial cancer treatment, highlighting innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

  8. Exploring Global Clinical Research Perspectives On RA Insights 2/5/2024

    Explore how the research into Rheumatoid Arthritis, which affects 17.6 million people worldwide, aims to improve treatment effectiveness and future interventions.

  9. GSK And Medable Discuss The Next Phase Of DCTs 3/10/2025

    GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.

  10. Global Prevalence And Clinical Trials Landscape Of AML 4/8/2024

    Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.